Sustained release drug formulation containing a tramadol salt

Details Sustained release drug formulation containing a tramadol salt Sustained release drug formulation containing a tramadol salt

1996-01-16

1997-02-11

Hulina, Amy

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

424469, 424474, 424480, 424482, 424488, A61K 922, A61K 928

Patent

active

056018428

ABSTRACT:
A drug formulation of tramadol or a tramadol salt in orally administrable tablet form containing at least one pharmaceutically acceptable matrixing agent is disclosed from which a non-moisture sensitive, physiologically acceptable tramadol salt is sustained released.

REFERENCES:
patent: 4389393 (1983-06-01), Schor et al.
patent: 4968508 (1990-11-01), Oren et al.
patent: 5073379 (1991-12-01), Klimesche et al.
patent: 5126145 (1992-06-01), Evenstad et al.
patent: 5132116 (1992-07-01), Sournac et al.
patent: 5268181 (1993-12-01), O'Neill et al.
Dow Chemical Brochure "Formulating for Controlled Release with METHOCEL Premium Cellulose Ethers" (1987).
Lapidus et al., "Drug Release from . . . ", J. Pharmaceutical Sci., vol. 57, No. 8, pp. 1292-1301 (1968).
Alderman, "A Review Of . . . ", Int. J. Pharm. Tech. & Prod. Mfr., vol. 5, No. 3, pp. 1-9 (1984).
Ford et al., "Importance of drug", Int. J. Pharmaceutics, vol. 40, pp. 223-234 (1987).

Affiliated with

Also associated with

Rating

Sustained release drug formulation containing a tramadol salt does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release drug formulation containing a tramadol salt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release drug formulation containing a tramadol salt will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-339880